Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours.

Trouillas J, Delgrange E, Wierinckx A, Vasiljevic A, Jouanneau E, Burman P, Raverot G.

Neuroendocrinology. 2019;109(1):70-76. doi: 10.1159/000499382. Epub 2019 Apr 3. Review.

2.

Pituitary Metastases: A Nationwide Study on Current Characteristics With Special Reference to Breast Cancer.

Schill F, Nilsson M, Olsson DS, Ragnarsson O, Berinder K, Edén Engström B, Dahlqvist P, Wahlberg J, Englund E, Burman P.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3379-3388. doi: 10.1210/jc.2019-00012.

PMID:
30892659
3.

The incidence of Cushing's disease: a nationwide Swedish study.

Ragnarsson O, Olsson DS, Chantzichristos D, Papakokkinou E, Dahlqvist P, Segerstedt E, Olsson T, Petersson M, Berinder K, Bensing S, Höybye C, Edén Engström B, Burman P, Bonelli L, Follin C, Petranek D, Erfurth EM, Wahlberg J, Ekman B, Åkerman AK, Schwarcz E, Bryngelsson IL, Johannsson G.

Pituitary. 2019 Apr;22(2):179-186. doi: 10.1007/s11102-019-00951-1.

4.

Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.

Ragnarsson O, Olsson DS, Papakokkinou E, Chantzichristos D, Dahlqvist P, Segerstedt E, Olsson T, Petersson M, Berinder K, Bensing S, Höybye C, Edén-Engström B, Burman P, Bonelli L, Follin C, Petranek D, Erfurth EM, Wahlberg J, Ekman B, Åkerman AK, Schwarcz E, Bryngelsson IL, Johannsson G.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2375-2384. doi: 10.1210/jc.2018-02524.

PMID:
30715394
5.

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide.

Bengtsson D, Schrøder HD, Berinder K, Maiter D, Hoybye C, Ragnarsson O, Feldt-Rasmussen U, Krogh Rasmussen Å, van der Lely A, Petersson M, Johannsson G, Andersen M, Burman P.

Endocrine. 2018 Dec;62(3):737-739. doi: 10.1007/s12020-018-1751-9. Epub 2018 Sep 24. No abstract available.

PMID:
30246233
6.

Temporal relationship of sleep apnea and acromegaly: a nationwide study.

Vouzouneraki K, Franklin KA, Forsgren M, Wärn M, Persson JT, Wik H, Dahlgren C, Nilsson AS, Alkebro C, Burman P, Erfurth EM, Wahlberg J, Åkerman AK, Høybye C, Ragnarsson O, Engström BE, Dahlqvist P.

Endocrine. 2018 Nov;62(2):456-463. doi: 10.1007/s12020-018-1694-1. Epub 2018 Jul 31.

7.

Aggressive pituitary tumours and carcinomas: two sides of the same coin?

Trouillas J, Burman P, McCormack A, Petersenn S, Popovic V, Dekkers O, Raverot G.

Eur J Endocrinol. 2018 Jun;178(6):C7-C9. doi: 10.1530/EJE-18-0250. Epub 2018 Mar 27. Review.

PMID:
29588294
8.

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.

McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P; ESE survey collaborators.

Eur J Endocrinol. 2018 Mar;178(3):265-276. doi: 10.1530/EJE-17-0933. Epub 2018 Jan 12.

PMID:
29330228
9.

A Validated Risk Model for 30-Day Readmission for Heart Failure.

Mahajan SM, Burman P, Newton A, Heidenreich PA.

Stud Health Technol Inform. 2017;245:506-510.

PMID:
29295146
10.

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.

Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM; European Society of Endocrinology.

Eur J Endocrinol. 2018 Jan;178(1):G1-G24. doi: 10.1530/EJE-17-0796. Epub 2017 Oct 18. Review.

PMID:
29046323
11.

Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.

Yuen KCJ, Mattsson AF, Burman P, Erfurth EM, Camacho-Hubner C, Fox JL, Verhelst J, Geffner ME, Abs R.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):768-777. doi: 10.1210/jc.2017-01542.

PMID:
29029108
12.

Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort.

Bengtsson D, Joost P, Aravidis C, Askmalm Stenmark M, Backman AS, Melin B, von Salomé J, Zagoras T, Gebre-Medhin S, Burman P.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3928-3932. doi: 10.1210/jc.2017-01401.

13.

Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly.

van der Lely AJ, Gomez R, Pleil A, Badia X, Brue T, Buchfelder M, Burman P, Clemmons D, Ghigo E, Jørgensen JOL, Luger A, van der Lans-Bussemaker J, Webb SM, Strasburger CJ.

Pituitary. 2017 Dec;20(6):692-701. doi: 10.1007/s11102-017-0835-5.

14.

Soil Microbiomes Associated with Verticillium Wilt-Suppressive Broccoli and Chitin Amendments are Enriched with Potential Biocontrol Agents.

Inderbitzin P, Ward J, Barbella A, Solares N, Izyumin D, Burman P, Chellemi DO, Subbarao KV.

Phytopathology. 2018 Jan;108(1):31-43. doi: 10.1094/PHYTO-07-17-0242-R. Epub 2017 Nov 21.

PMID:
28876209
15.

A permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?

Burman P, Dekkers OM.

Endocrine. 2017 Aug;57(2):356-358. doi: 10.1007/s12020-017-1325-2. Epub 2017 May 18. No abstract available.

PMID:
28523626
16.

Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions.

Burman P, van Beek AP, Biller BM, Camacho-Hübner C, Mattsson AF.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):1051-1058. doi: 10.1210/jc.2016-3402.

PMID:
28359095
17.

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.

Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Ragnarsson O, Skrtic S, Wahlberg J, Achenbach H, Uddin S, Marelli C, Johannsson G.

Eur J Endocrinol. 2017 Jun;176(6):715-725. doi: 10.1530/EJE-17-0067. Epub 2017 Mar 14.

18.

Integrative Analysis of Disease Signatures Shows Inflammation Disrupts Juvenile Experience-Dependent Cortical Plasticity.

Smith MR, Burman P, Sadahiro M, Kidd BA, Dudley JT, Morishita H.

eNeuro. 2017 Jan 18;3(6). pii: ENEURO.0240-16.2016. doi: 10.1523/ENEURO.0240-16.2016. eCollection 2016 Nov-Dec.

19.

Analyzing 30-Day Readmission Rate for Heart Failure Using Different Predictive Models.

Mahajan S, Burman P, Hogarth M.

Stud Health Technol Inform. 2016;225:143-7.

PMID:
27332179
20.

Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.

Burman P, Edén-Engström B, Ekman B, Karlsson FA, Schwarcz E, Wahlberg J.

Eur J Endocrinol. 2016 Jan;174(1):17-24. doi: 10.1530/EJE-15-0807.

PMID:
26582653
21.

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.

Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Sorensen HT, Stochholm K, Strasburger C, Swerdlow A, Thorner M.

Eur J Endocrinol. 2016 Feb;174(2):P1-9. doi: 10.1530/EJE-15-0873. Epub 2015 Nov 12.

22.

Unmasking Proteolytic Activity for Adult Visual Cortex Plasticity by the Removal of Lynx1.

Bukhari N, Burman PN, Hussein A, Demars MP, Sadahiro M, Brady DM, Tsirka SE, Russo SJ, Morishita H.

J Neurosci. 2015 Sep 16;35(37):12693-702. doi: 10.1523/JNEUROSCI.4315-14.2015.

23.

Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.

Marina D, Burman P, Klose M, Casar-Borota O, Luque RM, Castaño JP, Feldt-Rasmussen U.

Growth Horm IGF Res. 2015 Oct;25(5):262-7. doi: 10.1016/j.ghir.2015.07.003. Epub 2015 Jul 12.

PMID:
26188991
24.

ESE guidelines, why and how.

Dekkers OM, Burman P; ESE Clinical Committee.

Eur J Endocrinol. 2015 Aug;173(2):E1-2. doi: 10.1530/EJE-15-0625. No abstract available.

PMID:
26160135
25.

Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.

Bengtsson D, Schrøder HD, Andersen M, Maiter D, Berinder K, Feldt Rasmussen U, Rasmussen ÅK, Johannsson G, Hoybye C, van der Lely AJ, Petersson M, Ragnarsson O, Burman P.

J Clin Endocrinol Metab. 2015 Apr;100(4):1689-98. doi: 10.1210/jc.2014-4350. Epub 2015 Feb 3.

PMID:
25646794
26.

Correlates of functional outcome among stroke survivors in a developing country--a prospective community-based study from India.

Ghosal MK, Burman P, Singh V, Das S, Paul N, Ray BK, Hazra A, Banerjee TK, Basu A, Chaudhuri A, Das SK.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2614-21. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.001. Epub 2014 Sep 18.

PMID:
25238928
27.

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.

Nilsson AG, Marelli C, Fitts D, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Lennernäs H, Skrtic S, Johannsson G.

Eur J Endocrinol. 2014 Sep;171(3):369-77. doi: 10.1530/EJE-14-0327. Epub 2014 Jun 18.

28.

Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder.

Guha P, Bhowmick K, Mazumder P, Ghosal M, Chakraborty I, Burman P.

Indian J Clin Biochem. 2014 Jan;29(1):51-6. doi: 10.1007/s12291-012-0292-x. Epub 2013 Jan 10.

29.

Giant prolactinomas in women.

Delgrange E, Raverot G, Bex M, Burman P, Decoudier B, Devuyst F, Feldt-Rasmussen U, Andersen M, Maiter D.

Eur J Endocrinol. 2013 Nov 22;170(1):31-8. doi: 10.1530/EJE-13-0503. Print 2014 Jan. Review.

PMID:
24088550
30.

Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.

Burman P, Mattsson AF, Johannsson G, Höybye C, Holmer H, Dahlqvist P, Berinder K, Engström BE, Ekman B, Erfurth EM, Svensson J, Wahlberg J, Karlsson FA.

J Clin Endocrinol Metab. 2013 Apr;98(4):1466-75. doi: 10.1210/jc.2012-4059. Epub 2013 Mar 1.

PMID:
23457412
31.

National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden.

Ónnestam L, Berinder K, Burman P, Dahlqvist P, Engström BE, Wahlberg J, Nyström HF.

J Clin Endocrinol Metab. 2013 Feb;98(2):626-35. doi: 10.1210/jc.2012-3362. Epub 2013 Jan 7.

PMID:
23295463
32.

Cognitive dysfunction in stroke survivors: a community-based prospective study from Kolkata, India.

Das S, Paul N, Hazra A, Ghosal M, Ray BK, Banerjee TK, Burman P, Das SK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1233-42. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.008. Epub 2012 Jun 19.

PMID:
22721821
33.

[Traumatic brain injury can cause pituitary deficiency. Suggestions for guidelines for assessment of pituitary function].

Rosén T, Burman P, Dahlqvist P, Dahm P, Edén-Engström B, Ekman B, Höybye C, Jakobsson KE, Koskinen LO, Tölli A, Valdemarsson S, Ulfarsson T.

Lakartidningen. 2012 Mar 21-27;109(12):629-32. Review. Swedish. No abstract available.

PMID:
22624345
34.

Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernäs H, Skrtic S.

J Clin Endocrinol Metab. 2012 Feb;97(2):473-81. doi: 10.1210/jc.2011-1926. Epub 2011 Nov 23.

PMID:
22112807
35.

Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency.

Jørgensen AP, Fougner KJ, Ueland T, Gudmundsen O, Burman P, Schreiner T, Bollerslev J.

Growth Horm IGF Res. 2011 Apr;21(2):69-75. doi: 10.1016/j.ghir.2011.01.001. Epub 2011 Feb 3.

PMID:
21295507
36.

Phenological and phytochemical changes correlate with differential interactions of Verticillium dahliae with broccoli and cauliflower.

Njoroge SM, Vallad GE, Park SY, Kang S, Koike ST, Bolda M, Burman P, Polonik W, Subbarao KV.

Phytopathology. 2011 May;101(5):523-34. doi: 10.1094/PHYTO-08-10-0219.

37.

Large fat and skin necroses after deep subcutaneous injections of a slow-release somatostatin analogue in a woman with acromegaly.

Burman P, Besjakov J, Svensjö T.

Growth Horm IGF Res. 2010 Dec;20(6):438-40. doi: 10.1016/j.ghir.2010.10.004. Epub 2010 Nov 10.

PMID:
21071248
38.

Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency.

Ueland T, Jørgensen AP, Godang K, Fougner KJ, Aukrust P, Burman P, Bollerslev J.

Clin Endocrinol (Oxf). 2011 Jan;74(1):60-6. doi: 10.1111/j.1365-2265.2010.03884.x.

PMID:
21039720
39.

Acanthameba meningitis with successful outcome.

Saxena A, Mittal S, Burman P, Garg P.

Indian J Pediatr. 2009 Oct;76(10):1063-4. doi: 10.1007/s12098-009-0205-z. Epub 2009 Nov 12.

PMID:
19907944
40.

Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis.

Dekkers OM, Lagro J, Burman P, Jørgensen JO, Romijn JA, Pereira AM.

J Clin Endocrinol Metab. 2010 Jan;95(1):43-51. doi: 10.1210/jc.2009-1238. Epub 2009 Oct 30. Review.

PMID:
19880787
41.

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.

Igreja S, Chahal HS, Akker SA, Gueorguiev M, Popovic V, Damjanovic S, Burman P, Wass JA, Quinton R, Grossman AB, Korbonits M.

Clin Endocrinol (Oxf). 2009 Feb;70(2):259-64. doi: 10.1111/j.1365-2265.2008.03379.x. Epub 2008 Aug 15.

PMID:
18710468
42.

Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.

Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF.

Eur J Endocrinol. 2008 Nov;159(5):517-23. doi: 10.1530/EJE-08-0205. Epub 2008 Aug 15.

PMID:
18708436
43.

Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling.

Burman P, Lethagen A, Ivancev K, Johansson L, Sundin A.

Eur J Endocrinol. 2008 Oct;159(4):483-8. doi: 10.1530/EJE-08-0385. Epub 2008 Jul 14.

PMID:
18625689
44.

Kimura's disease--cytodiagnostic pointers: a case report.

Dilip S, Toi PCh, Burman PP, Ramdas A, Varghese RG.

Indian J Pathol Microbiol. 2007 Apr;50(2):420-2.

PMID:
17883097
45.

Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study.

Sathiavageeswaran M, Burman P, Lawrence D, Harris AG, Falleti MG, Maruff P, Wass J.

Eur J Endocrinol. 2007 Apr;156(4):439-47.

PMID:
17389458
46.

Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.

Pivonello R, Galderisi M, Auriemma RS, De Martino MC, Galdiero M, Ciccarelli A, D'Errico A, Kourides I, Burman P, Lombardi G, Colao A.

J Clin Endocrinol Metab. 2007 Feb;92(2):476-82. Epub 2006 Nov 14. Erratum in: J Clin Endocrinol Metab. 2007 May;92(5):1605.

PMID:
17105844
47.

Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant.

Parkinson C, Burman P, Messig M, Trainer PJ.

J Clin Endocrinol Metab. 2007 Jan;92(1):190-5. Epub 2006 Oct 31.

PMID:
17077131
48.

The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature.

Falleti MG, Maruff P, Burman P, Harris A.

Psychoneuroendocrinology. 2006 Jul;31(6):681-91. Epub 2006 Apr 18.

PMID:
16621325
49.

Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency.

Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P.

Eur J Endocrinol. 2006 Apr;154(4):537-43.

PMID:
16556716
50.

Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.

Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G.

Eur J Endocrinol. 2006 Mar;154(3):467-77.

PMID:
16498061

Supplemental Content

Loading ...
Support Center